Company Overview of Io Therapeutics, Inc.
Io Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapeutic compounds for cancer, and neurodegenerative and autoimmune diseases. The company offers retinoid and rexinoid molecule drugs for prostate, non small cell lung, breast, and pancreatic cancers; neurodegenerative diseases, such as Alzheimer’s and Parkinson’s diseases, traumatic brain injury, and other diseases; and autoimmune diseases, including multiple sclerosis and others. Io Therapeutics, Inc. was founded in 2010 and is based in Santa Ana, California.
1805 East Garry Avenue
Santa Ana, CA 92705-5851
Founded in 2010
Key Executives for Io Therapeutics, Inc.
Io Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Praetego, Inc.||United States|
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Io Therapeutics, Inc., please visit www.io-therapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.